India is set for record growth in 2023 after pharma manufacturers report surging international partnering at CPHI Frankfurt. Contract Manufacturing organisations (CMO) appear to be the biggest beneficiaries of new contracts, closely followed by API manufacturers in the country. In fact, for the first time Indian API manufacturing has surpassed the quality scores of even Europe’s leading API hub – Italy – in the CPHI Annual Survey.

Last week’s CPHI Frankfurt saw a return to event's pre-pandemic scale with the industry partnering at record pace and Indian companies reporting surging interest from the EU and in particular USA. Companies in both the USA and Europe are reportedly deepening ties with India’s pharma industry as a response to recent macro-sourcing changes.

“We have been growing extremely quickly in the last few years and this is being driven by an increasing volume of contract services work emerging from the United States – particularly for development projects. Biotechs are using our chemistry services and then going longer in development, while big pharma sees India as a keystrategic development hub,” commented, Ramesh Subramanian Chief Commercial Officer at Aragen.

India has seen improved scoresfrom international executives across all metrics in the new CPHI Annual Report and, mirroring this trend, CPHI & PMEC India expects representatives from more than 79 countries when the show opens later this month (29 November – 1st December).  

In fact, the countryhas seen record rises in many categories and has overtaken Japan, Switzerland, Italy and France in the overall rankings, finishing only behind the UK, Germany and the USA. The country was also identified by nearly 50% of pharma industry executives as thebiggest beneficiary of ‘geo-sourcing strategies’ in next three years. India recorded its largest ever improvements in scores for the quality of its ‘finished dose manufacturing’ and ‘API manufacturing’ – with a massive 15% gain in the latter category.

With these positive results as the event’s backdrop, the 16th CPHI & PMEC India will run in a hybrid form – with a two week online partnering platform either side of the in-person event at India Expo Centre (Greater Noida) in theNew Delhi Capital Region. Pharmaceutical machinery is predicted to be in high demand as both generic companies and CDMOs invest in next generation equipment like continuous processing and advanced analytical equipment to help maintain the country’s impressive 15% annualised growth rate.

“We are at a key moment for India as it achieves comparable and even improved quality with many European nations. This coupled with geo-sourcing strategies underway means that in the next year andthe year’s that followIndia is likely to see a sustained period as one of pharma’s fastest innovating and growing nations. What’s exciting for CPHI is that we are playing an integral role at the heart of this dynamism by empowering the country’s industry with the partnering it needs to fuel growth,” commented Olga Ponomareva-Stepnaya, brand manager for CPHI India.

CPHI India will feature India Pharma Week,along with the 6th annual Pre-connect congress, the Women in Pharma roundtable, the eco roundtable and theIndia PharmaAwards. The event will seearound 40,000 executives attend from more than 70 countries, of which nearly 50% are C-Suite and 65% have purchasing responsibility. Thousands of global companies will gather to get new insights and contacts in what is predictedto be pharma’s most competitive marketplace in 2023.

About CPHI
CPHI is the leading global community for pharmaceutical professionals, hosting a portfolio of digital and in-person connection opportunities across the whole pharma supply chain. Evolving our events to become part of an integrated digital package means the industry has more time, more flexibility and more opportunities to meet, learn and connect. CPHI is the world’s primary pharma event series, with the largest community, and our goal is to proactively inspire the pharma industry to create purposeful partnerships.

At the Heart of Pharma: connecting people and businesses from all over the world. At the heart of pharma, we act as catalysts for industry developments

For more information, please visit www.informamarkets.com

CPHI & PMEC India (29 November – 1st December 2022 at the India Expo Mart, Greater Noida, Delhi NCR – Delhi, India); CPHI China (20-22 December 2022 at SNIEC – Shanghai, China); Pharmapack Europe (1-2 Feb, 2023 at Paris Expo, Porte de Versailles - Hall 7.2, Paris); CPHI Japan (19-21 April, 2023 at the Big Sight Exhibition Centre – Tokyo, Japan); CPHI North America (25-27 April, 2023 at Pennsylvania Convention Center, United States), CPHI South East Asia (12-14 Jul  2023 at IMPACT, Thailand);  CPHI Barcelona (24-26 October 2023 at Fira Barcelona, Barcelona);

For media enquiries, please contact:
Alex Heeley or Nidhi Narain
De Facto Communications
T: +44 (0) 203 735 8165 /  +44 (0) 7834 785 764
E: n.narain@defacto.co.uk  / a.heeley@defacto.co.uk

Report Abuse